29-Jun-2020
The Diabetes Trials Unit is resuming the COPCOV trial in the UK following renewed approval from UK regulators.
This important global trial will answer the question whether health-care workers who take hydroxychloroquine, compared with a placebo, will have lower risk of getting COVID-19. COPCOV, which is a prevention rather than a treatment trial, will enrol healthcare workers from across the UK.
MHRA approval
[Health care workers can register your interest here]